• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    A capsule (60) for sampling in the intestine, comprising a body (60, 61) defining at least one sample receiving compartment (65) and having at least one inlet opening (63) for sample, and a mechanism (61) movable opening and / or closure of the opening controlled by the dissolution of a dissolvable material in the intestine.
    公开号:FR3052046A1
    申请号:FR1655187
    申请日:2016-06-07
    公开日:2017-12-08
    发明作者:Philippe Cinquin；Denis Favier；Thierry Alonso；Aziz Bakri；Nawel Khalef；Jacques Thelu；Sylvain Besson；Donald Martin
    申请人:Centre Hospitalier Universitaire de Grenoble；Universite Grenoble Alpes；
    IPC主号:
    专利说明:

    Intestinal sampling device
    The present invention relates to a device for taking samples in the intestine, in particular for research and diagnostic purposes. At a time when we consider the digestive system and its microbiota as a subject of major interest in human health, particularly in terms of pathology diagnosis, where we constantly develop new probiotics without really knowing or being in Because of their ability to know their effects throughout the intestine, there is a need for a means of making representative samples of specific parts of the tract. US Pat. No. 5,971,942 describes sampling capsules formed of an envelope delimiting an interior volume in which there is a low pressure, and provided with an opening closed by a seal able to dissolve in the intestinal medium, the intestinal liquid then being sucked inside the capsule by the pressure difference, and the closure of the capsule being obtained by the balance of the pressures out and in the capsule. Multi-compartment capsules or the use of multiple capsules with different dissolution rate joints can be used to collect samples at various locations. These capsules do not include a movable mechanism for opening and / or closing the opening controlled by the dissolution of a dissolvable material in the intestine. These capsules are limited in internal volume and require a low pressure inside the manufacture.
    It is an object of the present invention to provide a device for taking samples at different levels in the intestinal tract, preferably in a predetermined manner.
    Another objective of the invention is to propose such a device that makes it possible to collect variable volumes, while remaining easily swallowed by the patient.
    Another object of the invention is to provide such a device which is an acceptable cost and easy to use and recoverable. The invention therefore relates to a capsule for sampling in the intestine (small intestine or large intestine). The capsule comprises a body delimiting at least one sample receiving compartment and at least one sample admission opening (liquid or intestinal material) associated with an opening and / or closing mechanism controlled by the dissolution of the sample. a degradable / dissolvable material in the intestine. The entry of a sample through the opening can in particular be done passively by mechanical opening or suction by mechanical deployment of the compartment.
    The capsule may comprise a dissolvable material in the intestine (which means in contact with the contents of the intestine), which partially or completely surrounds the body of the capsule and whose dissolution releases the opening or causes a mechanism to cause this opening and / or aspiration. The capsule may comprise or house a mobile device for closing the opening which, in the initial state, is immobilized by a brake of dissolvable material in the intestine, and, after dissolution of this brake, is activated to close the opening. 'opening.
    Remarkably, devices of the invention have a variation of their external and internal volume following the dissolution or degradation of a material initially forcing them into a reduced volume form.
    Similarly, devices of the invention comprise several compartments which are successively connected to the opening.
    According to a feature of the invention, the capsule may be surrounded by a gastro-resistant material, allowing the unhindered passage of the stomach. Once this material dissolves inside the intestine, the capsule can work. The intestinal fluid can dissolve a degradable material closing an opening on the interior of the compartment, and / or can dissolve a degradable material binding the body in a collapsed form, the degradation releasing the body that can expand and open to the liquid intestinal tract, and / or dissolve a brake or the like to release the mobile device opening and / or closing. Those skilled in the art will readily understand that the choice of material and its rate of dissolution in the gut can be influenced to determine when the capsule is ready to go into operation. More than one layer of material, a layer of outer material to pass the barrier of the stomach, and at least one inner layer can be provided to prolong the intra-intestinal latency time before the capsule comes into operation. The invention thus relates to a capsule intended for sampling in the intestine, characterized in that it comprises a body delimiting at least one sample receiving compartment and comprising at least one sample admission opening, and a movable mechanism for opening and / or closing the opening controlled by the dissolution of a dissolvable material in the intestine. Preferably, the body of the capsule is wholly or partially surrounded by a dissolvable material (including several materials, as will be explained later, including a first gastro-resistant and a dissolvable material in the intestine after a residence time determined) in the intestine whose dissolution triggers or releases the movable mechanism of opening and closing the opening.
    In one embodiment, the body of the capsule may be constrained in one or more directions in a folded form within a degradable material in the intestine. Once this material dissolves inside the intestine, the capsule (the body of the capsule) is released and unfolds to take its active form, providing an opening and increased compartment volume compared to the non-deployed form . This also has the advantage of having a folded capsule easily swallowed by the individual or to reduce the volume so much that it is possible to swallow several at a time, especially combined in the same container (capsule or capsule, which can at the same time form the gastroresistant material). According to a modality, it is possible to have a series of folded capsules, preferably combined in a single larger capsule or capsule, to which a degradable material in the intestine confers dissolution rates in the different and predetermined intestines, making it possible to collect samples at different times of transit in the intestine. Preferably then, the capsules have recognition markers, for example a color or other sign to classify after collection.
    In one embodiment, the capsule is of cylindrical or substantially cylindrical shape. Advantageously, in accordance with the preceding paragraph, its body may be deployed axially and / or radially around the axis of the cylinder.
    In a first embodiment, the capsule is of the type whose body is initially constrained in a dissolvable material in the intestine, and has a cylindrical expanded form between two rigid disks joined by a spring or a stent separating them. The capsule may include a waterproof and expandable membrane connected to the disks to form the surface of the cylinder. Initially the membrane extends over a portion of the circumference of the cylinder and one of its free edges, preferably reinforced by an extensible or flexible rod (eg rope) integral with a spring designed to deploy the expandable membrane up to completely close the cylinder, said spring being initially constrained by a brake dissolvable material in the intestine. Preferably, the two disks are provided on their edge with a groove each cooperating with a spring connected to the ring, to drive the sealed membrane.
    In a second embodiment, the body of the capsule is constrained in two orthogonal directions in a folded form within the dissolvable material in the intestine. Of cylindrical shape, it is deployed axially and radially around the axis of the cylinder.
    The capsule may comprise, constrained in the dissolvable material in the intestine, at least one expandable tubular mesh structure in the two orthogonal directions, in particular of the mesh stent type, optionally in shape memory or superelastic material, eg in Ni-Ti alloy . Advantageously, this mesh structure is cylindrical. Its two bases can be secured to two discs of extensible material (eg elastomer) to accompany the radiated extension of the mesh structure. When the capsule unfolds, the two disks deviate from one another under the effect of the axial extension of the mesh structure. Each of the disks may be associated with a cylindrical wall of extensible material extending from the edge of the second disk (or near the edge of the disk). When the complete deployment of the capsule is reached and the sample entered into the compartment, the two cylindrical walls come into contact with each other, preferably overlap at least partially, and close the capsule.
    In a first embodiment, one of the bases of the tubular mesh structure can be supported on a first disc of integral extensible material. This first disc may be integral with a cylindrical wall of extensible material extending from the edge of the disc (or near the edge of the disc), inside the tubular mesh structure on a part of the surface thereof. . The other base of the tubular mesh structure can be supported on a second disc of extensible material. This second disk may be integral with a cylindrical wall of extensible material extending from the edge of the second disk (or near the edge of the disc), inside the tubular mesh structure. This wall is not deployed at rest. It can be associated with a deployment spring constrained in a position not deployed by a dissolvable material in contact with the contents of the intestine and designed to, after dissolution of this brake material, deploy the wall associated with the second disc to overlap with the less in part the wall associated with the first disk.
    In a second embodiment, one of the bases of the tubular mesh structure can be supported on a first disc of extensible material. This first disc may be integral with a cylindrical wall of extensible material extending from the edge of the disc (or near the edge of the disc), outside the tubular mesh structure on a portion of the surface thereof . The other base of the tubular mesh structure can be supported on a second disc of extensible material. This second disc may be integral with a cylindrical wall of extensible material extending from the edge of the second disc (or near the edge of the disc), outside the tubular mesh structure. It is possible to provide a device making it possible to constrain the meshed structure axially beyond its deployed rest position, and to dimension the cylindrical walls so that, in this position, a circumferential opening is cut out allowing intestinal fluid to enter the compartment. This device can be connected to the disks by a dissolvable material in the intestine, so that once the dissolution is made, the mesh structure takes its expanded form of rest closed by the walls. It can be a set of two springs in support staggered on a disc to which these springs are glued with a dissolvable glue with the intestinal fluid, so that after dissolving the offset support makes that the springs escape from each other, and the mesh structure takes its extended form of rest, and the cylindrical walls come into contact (preferably overlapping at least partially) to close the compartment.
    In another embodiment, the body of the capsule houses a blade-shaped structure comprising walls delimiting compartments radiated from a central axis, the structure being integral with a spring, for example a spring wire. torsion, or a mechanical device urging it in rotation. At least one dissolvable brake in contact with the contents of the intestine may be associated with each compartment to trigger the rotation and passage of the compartment in front of the opening after dissolution of the brake. The spring or the mechanical device can exert a constant stress, the rotation being prevented by the presence of an abutment against which a dissolvable brake rests. When the dissolvable brake of a compartment resting on the abutment is dissolved or degraded, the abutment is released and the blade-shaped structure turns one step until the abutment between the abutment and the next brake, although that said compartment is then placed in front of the opening and the sample can enter. At the dissolution of the brake of the next compartment, the structure turns a step and it is the next compartment which is found in front of the opening, and so on. All the brakes may be in contact with the intestinal fluid, the brakes having predetermined degradation rates and decreasing from the brake associated with the opening of the first compartment and that associated with the last compartment. This can be achieved by the choice of material or the thickness of the brake.
    In another embodiment, the body of the capsule is formed of a cage comprising a base structure surrounded by a flexible and elastic waterproof membrane, for example latex or silicone material, the cage having naturally (at rest, deployed) an ovoid shape between two ends. It may especially be a cage made of shape memory material or superelastic, e.g. NiTi alloy. The cage is initially constrained by a material, in particular one or more strips of degradable material in the intestine, disposed around the sealed membrane, and preferably the non-deployed form is cylindrical. The structure further has an opening at one of its ends or an opening at each of its ends. The dissolution or degradation of the band or strips of degradable material allows the structure to expand and suck the intestinal fluid into its interior.
    According to a first modality, at one end or both ends, there is a non-return valve, allowing the suction of liquid in the cage when the latter is deployed, the valve preventing the exit of the liquid once the cage filled. Any type of non-return valve may be employed, having a movable part allowing the opening of the liquid inlet inlet when the cage is deployed, and closing this inlet when the cage is filled. As a simple example, the flexible membrane is turned on itself like a thermowell, towards the inside of the cage, forming a non-return valve. The intestinal liquid is sucked inside the capsule at the time of swelling of the cage, it freely passes the opening by removing the membrane. Once the capsule is filled, the liquid can not come out since the elasticity and the shape of the membrane is this time a barrier to the liquid.
    According to a second embodiment, the two openings are associated with a movable opening and closing mechanism, with a sealing pad associated with said movable mechanism to ensure the closing of these openings only when the structure has deployed. These buffers may advantageously be mounted on a rod extending axially through the structure and openings and cooperating with bearings placed in these openings. In particular, the mechanism comprises a rod extending axially through the structure, bearings placed in these openings, each bearing having a central orifice of diameter greater than the diameter of the rod, the sealing pads being mounted on the stem. the interior of the mesh structure at a location bringing them bearing on the bearings when the structure has taken its ovoid form. The inlet opening is formed by the space left by the rod in the central port of the bearings, and the deployment of the mailed structure sucks the sample through this space, until the buffers come to bear on the bearings.
    The body may be formed of a cage comprising a base structure formed of bars surrounded by a flexible and elastic waterproof membrane, the cage having naturally (at rest) an ovoid shape. The cage is constrained in particular in cylindrical form by any appropriate means, for example one or more strips of dissolvable material in contact with the intestinal liquid
    In a variant, the cage is in the form of a stent-shaped stent mesh structure, the cage having naturally (deployed at rest) an ovoid shape.
    This embodiment is particularly, but not exclusively, suitable for collecting samples of relatively large volume, especially between about 0.5 ml and about 2 ml.
    By degradable or dissolvable material (we use in the text indifferently one word or the other, unless otherwise indicated), we mean different types of chemical, physicochemical and / or enzymatic mechanisms.
    The material may be fully soluble, or one or more component (s) of the material may be soluble. Thus, the solubility or the degradation / digestion of the material can be obtained by dissolving a main component such as a polymer or a component such as a binder, leading to a total or partial dissolution of the material, sufficient to release the capsule of this material. It may also have, instead of or in addition, an enzymatic mechanism with digestion of a main component such as a polymer (or a mixture of polymers) or a component such as a binder, leading to total digestion or partial of the material, sufficient to release the capsule of this material. These materials are able to undergo this dissolution or degradation in the physiological conditions of the intestine. As degradable / dissolvable materials in the intestine, mention may be made of synthetic polymers such as PVA (polyvinyl alcohol), poly (acrylic acid) (Carbomer), polyethylene oxides, polymethacrylates, poly lactic / glycolic acid (PLGA) ... Natural polymers such as polysaccharides: Agarose, Chitosan, Alginates, or proteins such as gelatin or semi-synthetic such as cellulose derivatives: Hydroxypropyl methyl cellulose (HPMC), Ethyl cellulose hydroxide (HEC), and Carboxyl methyl cellulose (CMC), gelatin, triglycerides (wax) ... Different degradation rates can be obtained as is known to those skilled in the art, for example by the choice of material, for example nature of the material, of the polymer, presence or absence of additives acting on the solubility of the material, the polymer or a component, for example a binder, weight composition when there are several components, nature of the degradation enzymes in the case where the degradation is enzymatically, and / or the thickness of the material.
    As gastro-resistant materials, mention may be made of cellulose acetophthalate (CAP), carboxymethylcellulose (CMC), hypromellose acetate succinate (HPMCAS), polymethacrylates, polyvinylacetate phthalate (PVAP), shellacs (shellac ) ...
    By alloy or shape memory metal is meant a material which has been conditioned by methods known to those skilled in the art, to take a certain shape at 37 ° C in the absence of other mechanical stress exerted on it.
    Several small capsules can be combined together in a capsule or large capsule, as it has been said. It is also possible to have a string of several small capsules, connected by cord or glued together with a material that does not dissolve in the stomach and intestine.
    Colored markers have been mentioned to allow recognition of recovered capsules. It is also possible to use a silicon chip, an RFID chip or the like.
    The capsules may also include a metal part to locate them inside the body and / or facilitate their recovery in the faeces using a magnet or other magnetic device. The invention will now be described in more detail with the aid of embodiments taken by way of nonlimiting examples with reference to the appended drawing in which: FIG. 1 represents a schematic three-quarter view of a capsule cylindrical strain in a dissolvable coating in the intestine according to a first embodiment. FIGS. 2-4 show schematic views of the capsule of FIG. 1, deployed after dissolution of the coating, in successive open configurations (FIG. 2), during closure (FIG. 3) and closed configuration (FIG. 4). . These views are in section along a plane containing the (horizontal) axis of the capsule. - Figure 5 shows a schematic view of a meshed capsule constrained in a dissolvable coating in the intestine according to a second embodiment. - Figures 6 and 7 show schematic views of the capsule of Figure 5, deployed after dissolution of the coating, in successive configurations open (Figure 6) and closed (Figure 7). These views are in section along a plane containing the (horizontal) axis of the capsule. - Figure 8 shows a schematic view of a meshed capsule constrained in a dissolvable coating in the intestine according to a third embodiment. - Figures 9 and 10 show schematic views of the capsule of Figure 8, deployed after dissolution of the coating, in successive configurations open (Figure 9) and closed (Figure 10). - Figure 11 shows an exploded schematic view of a capsule according to a fourth embodiment.
    Figure 12 is a schematic representation in elevation of the portion of the capsule of Figure 11, defining six compartments.
    Figure 13 shows a schematic elevational view of a capsule according to a fifth embodiment.
    FIG. 14 represents a schematic sectional view of the capsule of FIG. 13, in section along a plane containing the (horizontal) axis of the capsule, before and after deployment of the capsule and aspiration of sample, according to a first modality . FIG. 15 represents a schematic sectional view of the capsule of FIG. 13, in section along a plane containing the (horizontal) axis of the capsule, according to a second modality.
    Figure 16 shows a schematic elevational view of a capsule according to a sixth embodiment.
    Figure 1 shows a schematic view of three-quarters of a capsule 1 constrained in a coating 2 dissolvable in the intestine according to a first embodiment. The assembly forms a cylinder whose dimensions will vary, according to different embodiments.
    In a first embodiment, the capsule of the type shown in FIG. 1 has the following dimensions: from 1 to 6 mm, for example 4 mm in diameter, and from 1 to 6 mm, for example 4 mm in length. Thanks to these reduced dimensions, several, for example 5, 10, 15 or 20, of these capsules may be contained in a large capsule of larger dimensions, for example of length 25 mm and 12 mm in diameter, capable of being taken by the patient orally.
    In a second embodiment, the capsule of the type shown in FIG. 1 has the following dimensions: 6 to 20 mm, for example 12 mm in diameter, and 10 to 30 mm, for example 25 mm in length. Thanks to these dimensions each capsule thus formed is able to be taken by the patient orally.
    As can be seen in Figures 2-4, after dissolution of the coating 2, the capsule 1 is deployed. The capsule 1 has a cylindrical expanded form between two rigid disks 3 joined by a first spring 4 separating them, each of the disks having a circular groove (not shown) on its edge. The capsule has a tight and expandable membrane 5 connected to the discs 3 to form the surface of the cylinder. Initially (when the capsule 1 has deployed after dissolution of the coating 2) the membrane 5 extends over a portion of the circumference of the cylinder, the free portion forming the admission opening of the sample shown by the arrow 6. One of the free edges of the membrane 5 is secured to a rope 7 expandable and secured to two cylindrical springs (helical) 8 each disposed in a groove of a disc 3. These springs 8, when relax after being released, are designed to drive the rope 7 and deploy the expandable membrane 5 gradually and until fully close the cylinder, the springs 8 driving the rope 7 in a rotational movement guided in the grooves of the discs 3. Au rest, these springs 8 are compressed and blocked by two brakes 9 in dissolvable material in contact with the intestinal contents, each of the brakes being disposed at the ends of the rope 7 in contact with the discs 3. see in Figure 3 that the brakes 9 have disappeared, dissolved in contact with the intestinal fluid, and that the rope 7, under the action of the springs 8, began to close the inner space or compartment 10 of the capsule. In Figure 4, the movement has ended and the capsule is closed, the inner compartment being filled with intestinal matter (the sample). The coating 2 is selected for dissolution in the intestine at a predetermined time, so that the sampling takes place in the desired intestinal compartment. In particular, it is planned to produce several batches of capsules with specific coatings for each batch, leading to different dissolution rates. It is then possible to administer to the individual capsules of these different batches, to take samples at different predetermined locations in the intestine.
    Advantageously, the capsules of each batch have a particularity (for example the color of the disks) making it possible to identify them.
    Figure 5 shows a schematic view of a cylindrical mesh capsule constrained in a dissolvable coating in the intestine, according to a second embodiment. The dimensions may be the same as those described for the embodiment of FIG. 1, for a set of small capsules that can be combined in a larger capsule for oral administration, or for a larger capsule intended to be administered directly. Similarly, these capsules and their dissolvable coating in the intestine may be as described for the previous embodiment, so as to have capsules having coatings at different dissolution rates.
    The capsule comprises, constrained in the dissolvable material in the intestine, a tubular mesh structure extensible in both orthogonal directions (in the axis of the cylinder and radiated manner). This mesh structure is formed of a stent 12 constrained in both directions (Figure 5) and deployed (Figures 6 and 7) between two discs 13 forming the bases of the cylindrical shape of the capsule. One of the disks 13 is secured to a cylindrical wall 14 forming a cylindrical portion delimiting the sample receiving compartment. The other disc 13 is secured to a second cylindrical wall 15 having, at rest, a truncated cone-shaped directed towards the center of the compartment. The disks and walls are made of extensible flexible material, for example an elastomer or compressed tissue (e.g. shirred), having, for example, pores permeable to water and stopping microorganisms, including bacteria. The two walls 14 and 15 are located inside the mesh structure. A second stent 16, smaller than the previous one, is placed in the compartment at the right of the wall 14, temporarily fixed to this wall by a glue that rapidly degrades in contact with the intestinal liquid (for example PVA, polymethacrylates, amylose, HPMC. ..). This stent is designed to deploy radially only. This stent is constrained by a degradable material in the intestinal environment.
    When administered to an individual, the capsule is folded as shown in Figure 5. In the intestine, the layer of material 11 will dissolve causing the deployment in both directions of the stent 12 and, under its action, The medium or intestinal liquid can then enter the compartment thus sketched by the opening 18. Under the effect of this liquid entering the compartment, the layer of material 17 is in turn dissolved, which causes the radiated deployment of the stent 16 which will come to apply to the inner face of the wall 15, pushing it outwards, until it comes to bear against the wall 14 on a zone of overlay and closes the compartment 19 (Figure 7). In addition, a scratch and / or magnetization closure can be provided to optimize the closure of the compartment 19. By way of example, the length of the capsule is 2 mm and its height (cylinder diameter) from 4.5 mm to Figure 5, then goes to 4 mm in length and 9 mm in height in Figure 6 and the volume of the compartment is then 254 μΙ.
    Figure 8 shows a schematic view of a cylindrical mesh capsule constrained in a dissolvable coating in the intestine according to a third embodiment. The dimensions may be the same as those described for the embodiment of FIG. 1, for a set of small capsules that can be combined in a larger capsule for oral administration, or for a larger capsule intended to be administered directly. Similarly, these capsules and their dissolvable coating in the intestine may be as described for the previous embodiment, so as to have capsules having coatings at different dissolution rates.
    The capsule comprises, constrained in the dissolvable material in the intestine, a tubular mesh structure extensible in both orthogonal directions (in the axis of the cylinder and radiated manner). This mesh structure is formed of a stent 22 constrained in both directions (Figure 8) and deployed (Figures 9 and 10) between two discs 23 forming the bases of the cylindrical shape of the capsule. The two discs 23 are each integral with a cylindrical wall 24, respectively 25, forming two cylindrical portions delimiting the sample receiving compartment. The disks and walls are made of extensible flexible material, for example an elastomer or compressed tissue (e.g. shirred), having, for example, pores permeable to water and stopping microorganisms, including bacteria. The cylindrical walls carried by the disks are located outside with respect to the mesh structure. Two springs 26 are placed in the compartment to the right of the disks 23 to which they are temporarily fixed by a polymer rapidly dissolved by the intestinal liquid (see previous example), the two springs being fixed together in the center of the compartment, via a disk 27 on either side of which the springs are in opposition in an off-set manner, and a glue rapidly dissolved by the intestinal fluid. These springs 26 have a force greater than that of the stent 22 in the axial direction, it will be seen that this allows them to force the deployment of the stent in the axial direction beyond the rest position of the expanded stent 22.
    When administered to an individual, the capsule is folded as shown in Figure 8. In the intestine, the layer of material 21 will dissolve causing deployment in both directions of the stent 22, and at the same time disks 23 and walls 24 and 25. This also allows the deployment of the springs 26 in the axial direction, constraining the stent 22 beyond its rest position. The dimensions of the walls 24 and 25 are such that, as long as the springs are deployed, their facing edges are not in contact providing an opening 28 for the entry of intestinal fluid into the compartment (Figure 9). Under the effect of this liquid entering the compartment, the glue immobilizing the springs 26 dissolves, releasing the latter, then the support offset of the springs on the disk 27 causes the springs to disengage from one another releasing the stent 22 which takes its extended rest position, causing the walls 24 and 25 to come into contact to close the compartment 29 which then encloses the sample (Figure 10). For example, the length of the capsule is 2 mm and its height (diameter of the cylinder) of 4.5 mm in Figure 8, then goes to 4 mm in length and 9 mm in height in Figure 6 and finally to 2 mm long and 9 mm high in Figure 10. Compartment volume: 127 μ1.
    FIG. 11 represents an exploded schematic view of a cylindrical capsule according to a fourth embodiment. This capsule 30 comprises, from top to bottom, a base 31, a casing 32 with vertical slot 33, a carousel 34 provided with a plurality of radiated compartments 35 and a vertical central orifice 36, a drive shaft 37 connected to a workpiece 38. Once assembled, the slot 33 can be successively in front of the compartments 35 so that intestinal liquid can be taken, and the drive shaft 37 comes to couple inside the central hole of the carousel 34. Figure 12 shows a carousel or barrel of 6 compartments ..
    Various solutions for rotating the carousel can be envisaged. A first is a mechanical device for rotating the shaft 37, for example of the watchmaker type or kitchen minute-counter, miniaturized.
    A second is that the shaft 37 is a twist wire, or shape memory, which tends to want to return to its rest position or its initial shape. In this case, it is necessary to slow down this propensity so that the rotation of the carousel and the presentation of a compartment 35 in front of the slot 33 is controlled and in accordance with the sampling process within the intestine.
    In the embodiment of FIGS. 11 and 12, the rotary drive device is formed by the combination of a torsion spring wire 37, a disc 38 carrying, on the periphery, brakes 39a-39f of dimensions increasing (thus involving different dissolution times), the disc being surrounded by sealing flanges 40 and 41. The casing 32 carries at the upper corner of its slot 33, a fixed stop 42 on which a brake whacks, then when this brake is degraded, the torsion spring wire 37 rotates the barrel one step (one compartment) until the next brake comes to rest on the stop 42. For example, a first assembled capsule is 25 mm high for a diameter of 12 mm, a second is 12 mm in height and 10 mm in diameter. These dimensions can be varied within limits making oral ingestion possible. The number of compartments (for example from 5 to 20) can then be varied and, at equal size, the volume of each compartment is reduced as the number increases.
    FIGS. 13-15 show a schematic view of a capsule according to a fifth embodiment, operating with a principle of aspiration of the intestinal liquid, but without it being necessary to put the internal compartment under low pressure in the manufacture of the capsule.
    Figure 14, top view, shows the capsule 40 in its initial state, as administered to an individual. This is a tube 41 made of NiTi alloy cut longitudinally (for example by laser) except at the ends where two end portions 42 remain and subjected to a treatment conferring on it an expanded shape memory as in FIG. with bars 53). Cylindrical bearings 43 are fixed inside the end portions and a rod 44 extends axially in the tube 41 and the bearings 43. This rod protrudes outside the tube 41 and ends at both ends thereof. a sealing pad 45, for example elastomer. Two other similar sealing pads 46 are placed on the rod, inside the tube and near the bearings 43. The tube 41 is surrounded by a membrane (schematically represented in FIG. 14, numeral numeral 50) of material soft silicone and resistant to the intestinal environment. Then are applied around this membrane, one or more strips (not shown) of degradable material in the intestine, which constrains the capsule in the tubular form (Figure 14, top). After dissolution of this or these strips, the tube 41 tends to assume its expanded form, the buffers 45 then no longer ensure sealing at the bearings, the intestinal liquid being sucked by the slot 52 opening admission opening . When the capsule is fully deployed, the pads 46 come into contact with the bearings and seal the capsule, containing the sample.
    FIG. 15 shows a simpler variant, in which the end parts of the capsule house valves 47 of the balloon valve type with spring 48 and ball 49 sealing, allowing only the admission of intestinal liquid into compartment 51, during the deployment thereof after degradation of the band or strips of degradable material. By way of example, the dimensions are chosen for a compartment volume of 150 to 300 μΙ. For example, one can start from a cylinder 41 6 mm in diameter and 8 mm in length, to obtain a sample volume sucked about 150 μΙ into the deployed tube.
    In another embodiment, in Figure 16, the body of the capsule 60 is formed of a cage 61 for example of shape memory material, e .g. NiTi alloy naturally having (at rest) an ovoid shape. The cage is wrapped with a flexible and elastic membrane 62, for example latex or silicone adjusted to the shape of the cage at rest. The membrane completely obstructs one of the two openings and leaves the other 63 open, as would a glove finger covering the cage. At the open end, the flexible membrane is turned over on itself like a thermowell, and is introduced inside the cage. In this embodiment, the part 64 of the membrane located inside plays the role of a non-return valve 64. Then are applied around this membrane, one or more strips (not shown) of degradable material in the intestine, which constrains the capsule into a tubular form. After dissolution of this or these bands, the cage 60 tends to assume its expanded form The intestinal liquid is sucked inside the capsule 65 at the time of swelling of the cage, it freely passes the opening 63 by spreading the membrane. Once the capsule is filled, the liquid can not come out since the elasticity and the shape of the membrane is this time a barrier to the liquid. The internal pressure of the liquid tends to swell the membrane at 64, which forms rounded structures facing each other and obstructing the opening.
    Different degradation rates can be conferred on the dissolvable materials usable in the foregoing examples and other possible embodiments of the invention. These controlled degradation rates can be obtained as is known to those skilled in the art, for example by the choice of material, for example nature of the material, the polymer, presence or absence of additives acting on the solubility of the material, the polymer or component, for example a binder, weight composition when there are several components, nature of the degradation enzymes in the case where the degradation is enzymatically, and / or the thickness of the material.
    As we have seen, there may already be an outer layer or shell of gastro-resistant material. It may be in particular a coating or a capsule into which the device is inserted.
    There may then be one or more layers or one or more brakes or other dissolvable devices, the dissolution of which will open a sample compartment and / or trigger a sampling.
    For embodiments using layers or envelopes of materials, the following clarifications can be made. A / Coating in a single layer:
    The quality, the amount, the degree of substitution of the polymer (s), and the thickness of the layer can be used to modulate the time required to activate or release the function. The layer can be composed of: An enteric and soluble polymer at the pH of the small intestine and in which are integrated other polymers, excipients that allow to modulate the duration of erosion of the coating (as indicated in point B below). Of a polymer insoluble in the gastrointestinal tract (GIT) and non-erodible (eg ethylcellulose, acrylate and methacrylate ...) whose porosity is controlled and thus the diffusion of water, the dilation of the device, eg stent will cause bursting of the coating layer. A mixture of insoluble and GIT-soluble polymers (eg a mixture Ethyl cellulose-Hydroxypropylmethylcellulose HPMC). B / Coating in several layers: I - An outer layer:
    We can use :
    A gastro-resistant film or envelope whose solubility depends on the standard pH, for example, cellulose acetophthalate, certain methacrylate ester copolymers, etc., and which dissolve only at basic pH's.
    A membrane that is insoluble in GIT semi-permeable but can break under the pressure induced by effervescent agents, super-disintegrating (Croscaramellose), osmosis (NaCl) or polymers that swell on contact with water (HPMC). 2- Inner layers: There may be one or more inner layers composed of one or more polymers whose disintegration can be activated and controlled in several ways. The quality of the polymer, number and thickness of the layers can be used to modulate the time required to activate the device.
    The disintegration of the coating can be done using:
    Polymers which erode by dissolution, by enzymatic digestion, or by any other stimulus such as pH variation
    Hydrophilic polymers such as hyroxypropyl methylcellulose cellulose (HPMC), hydroxyethylcellulose (HEC) and hydroxypropyl cellulose (HPC) which swell and erode on contact with water. The control of the swelling speed makes it possible to control the time necessary for the water to reach the device and activate its expansion.
    权利要求:
    Claims (11)
    [1" id="c-fr-0001]
    claims
    1. Capsule (1, 10, 20, 30, 40, 60) for sampling in the intestine, characterized in that it comprises a body (3, 5, 13-15, 23-25; , 32, 39; 41, 50; 60, 61) defining at least one sample receiving compartment (10, 19, 29, 35, 51, 65) and having at least one opening (6, 18, 28, 33 , 52, 63), and a mechanism (4, 8; 12, 16; 22, 26; 34; 37; 44; 61) movable opening and / or closing of the controlled opening by dissolving a material (2, 9; 11, 17; 21) dissolvable in the intestine.
    [2" id="c-fr-0002]
    2. Capsule according to claim 1, characterized in that the body is wholly or partially surrounded by a dissolvable material in the intestine, the dissolution of which triggers or releases the mechanism (4, 8; 12, 16; 22, 26; 44) movable opening and closing of the opening.
    [3" id="c-fr-0003]
    3. Capsule according to claim 2, characterized in that the capsule (1) is constrained in a direction in a folded form inside the material (2) dissolvable in the intestine.
    [4" id="c-fr-0004]
    4. Capsule according to claim 3, characterized in that the body (3, 5) of the capsule (1) has a cylindrical expanded form between two rigid discs (3) joined by a spring (4) separating them, in that the capsule comprises a tight and expandable membrane (5) connected to the discs (3) to form the surface of the cylinder, in that initially the membrane (5) extends over a part of the circumference of the cylinder and one of its free edges is secured to a rod (7) integral with a spring (8) designed to deploy the expandable membrane (5) to fully close the cylinder, said spring (8) being initially constrained by a brake (9) in dissolvable material in the intestine.
    [5" id="c-fr-0005]
    5. Capsule according to claim 2, characterized in that the capsule (10, 20) is constrained in two orthogonal directions in a folded form inside the dissolvable material in the intestine.
    [6" id="c-fr-0006]
    6. Capsule according to claim 5, characterized in that it comprises, constrained in the dissolvable material in the intestine, at least one tubular mesh structure (12) expandable in both orthogonal directions, in that, one of the bases of the tubular mesh structure is supported on a first disc (13) of extensible material integral with a wall (14) of extensible material extending from the edge of the disc and inside the tubular mesh structure, and in that the other base of the tubular mesh structure (12) rests on a second disc (13) of extensible material integral with a wall (15) of extensible material extending from the edge of the second disc, associated a spring (16) of deployment constrained by a material (17) dissolvable in the intestine and designed to, after dissolution, deploy the wall (16) associated with the second disk so that it comes close the opening (18) in ent rant in contact with the wall (14) associated with the first disk.
    [7" id="c-fr-0007]
    7. Capsule according to claim 5, characterized in that it comprises, constrained in the material dissolvable in the intestine, at least one structure (20) tubular mesh extensible in both orthogonal directions, in that one of the bases of the tubular mesh structure is supported on a first disc (23) of extensible material integral with a cylindrical wall (24) of extensible material extending from the edge of the disc, outside the tubular mesh structure on a part of the surface thereof, in that the other base of the tubular mesh structure is supported on a second disc (23) of extensible material integral with a cylindrical wall (25) of extensible material extending from the edge of the second disk, outside the tubular mesh structure, in that a device constrains the meshed structure axially beyond its deployed rest position, in which the opening is formed opening (28), in that this device is connected to the discs (23) by a dissolvable material in the intestine, so that once the dissolution is made, the mesh structure takes its extended form of rest closed by the walls ( 24, 25).
    [8" id="c-fr-0008]
    8. Capsule according to claim 1 or 2, characterized in that the body (30) houses a structure (35) in the form of blades having walls defining compartments (35) radiated from a central axis, the structure being secured to a spring (37) urging it in rotation, and in that a dissolvable brake in the intestine is associated with each compartment to trigger the rotation and the passage of the compartment in front of the opening after dissolution of this brake.
    [9" id="c-fr-0009]
    9. Capsule according to claim 1 or 2, characterized in that the body (41) is formed of a cage comprising a base structure surrounded by a flexible membrane and flexible (50) elastic, the cage naturally having an ovoid shape in that the cage is initially constrained by a dissolvable material in the intestine, said structure further having an opening (52) at its ends and for each opening a sealing pad (46) associated with said movable mechanism to provide the closing these apertures (52) only when the structure has deployed.
    [10" id="c-fr-0010]
    10. Capsule according to claim 9, characterized in that the mechanism comprises a rod (44) extending axially through the structure, bearings (43) placed in these openings, each bearing having a central orifice (52) of diameter greater than the diameter of the rod, the sealing pads (46) being mounted on the rod at a location bringing them bearing on the bearings when the structure has taken its ovoid form.
    [11" id="c-fr-0011]
    11. Capsule according to claim 1 or 2, characterized in that the body (60) is formed of a cage comprising a base structure surrounded by a flexible membrane and elastic (50, 61) flexible and elastic, the cage naturally having a ovoid shape, in that the cage is initially constrained by a dissolvable material in the intestine, said structure further having at least one opening (63) at one end and a non-return valve placed in the opening (63).
    类似技术:
    公开号 | 公开日 | 专利标题
    EP3463100A1|2019-04-10|Device for taking an intestinal sample
    JP2020524062A|2020-08-13|Devices and methods for collecting gastrointestinal samples
    US20140128964A1|2014-05-08|Stent Seals and Methods for Sealing an Expandable Stent
    FR3050635A1|2017-11-03|INFLATABLE AND DETACHABLE BALLOON FOR USE IN A BODY CAVITY, TREATMENT NECESSARY AND DRAINING METHOD THEREOF
    JP2013540464A|2013-11-07|Devices and methods for dilating sinus openings and treating sinusitis
    CN108601930B|2021-12-14|Drug eluting balloon
    PT612520E|2001-12-28|DEVICES FOR ADMINISTRATION BY OSMOTIC DISCHARGE DISAGREGED BY PH
    US10918597B2|2021-02-16|Gastroretentive dosage forms for sustained drug delivery
    US20190307593A1|2019-10-10|Expanded device
    EP2793747A1|2014-10-29|Stent prosthesis intended to be implanted in the digestive tract of a patient
    EP3700431B1|2021-12-08|Device for collecting intestinal fluid
    FR2914860A1|2008-10-17|MULTILAYER SPHEROIDS WITH ANTIPALUDITIC ACTION IN WHICH ONE OF THE LAYERS CONTAINS ARTESUNATE
    WO2008096606A1|2008-08-14|Device for checking for lumen passage and method of checking for lumen passage
    FR3005846A1|2014-11-28|METHOD AND DEVICE FOR DETECTING THE ATROPHY OF A NATURAL CONDUIT SURROUNDED BY AN OCCLUSION SYSTEM
    CN209967154U|2020-01-21|Inflatable balloon and catheter
    WO2008037890A2|2008-04-03|Intragastric balloon with marked catheter
    WO2020185326A1|2020-09-17|Devices and methods for collecting gastrointestinal samples
    TW202106280A|2021-02-16|Capsule for storing lubricant
    BE431133A|
    Waldner et al.2014|Development of a dosage form for accelerated release
    WO2021232394A1|2021-11-25|Digestive tract cast-off cell enrichment device
    FR3060967A1|2018-06-29|FLUIDIC OCCLUSION DEVICE BY CLOSING
    JP2019534744A|2019-12-05|Device for sampling gastrointestinal substances
    CN111214259A|2020-06-02|Gastric juice sampling capsule
    JP2018193301A|2018-12-06|Sustained-release multi-layer micro needle that can be cut off from base or sheet
    同族专利:
    公开号 | 公开日
    US20190298318A1|2019-10-03|
    FR3052046B1|2021-12-24|
    EP3463100A1|2019-04-10|
    CN109890298A|2019-06-14|
    WO2017211872A1|2017-12-14|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    WO1979000811A1|1978-03-22|1979-10-18|J Pawelec|Device for study of the alimentary canal|
    DE19801573A1|1998-01-19|1999-07-22|Suchatzki Bernd Ulrich Dr|Hollow body to collect digestive juices for diagnosis|
    US20070173738A1|2001-05-17|2007-07-26|Fargklamman Ab|Sampling device and method for obtaining samples of internal body substancesand method for producing a sampling device|
    WO2005046485A1|2003-11-12|2005-05-26|FäRGKLäMMAN AB|Sampling device, method of producing a sampling device and use of a sampling device|
    US20160038086A1|2013-03-15|2016-02-11|Mars, Incorporated|Sampling device|
    US5971942A|1996-12-03|1999-10-26|Gu; Howard H.|Intestinal fluid sampler|
    EP1530950A1|2003-11-12|2005-05-18|Färgklämman AB|Sampling device and method of producing thereof|
    CN1631323A|2004-11-19|2005-06-29|华南理工大学|Remote control electromagnetic imbibition type gastrointestinal tract sampling microcapsule|
    CN101365388B|2006-01-12|2011-03-23|多种活检标本有限责任公司|A sampling apparatus for taking a number of samples|CA3084052A1|2017-12-06|2019-06-13|James Phillip Jones|Sampling capsule system|
    US10980482B2|2017-12-06|2021-04-20|James Phillip Jones|Sampling capsule system and methods|
    CN110974311A|2019-12-24|2020-04-10|华中科技大学鄂州工业技术研究院|Intestinal microorganism collection capsule|
    法律状态:
    2017-05-30| PLFP| Fee payment|Year of fee payment: 2 |
    2017-12-08| PLSC| Publication of the preliminary search report|Effective date: 20171208 |
    2018-04-27| PLFP| Fee payment|Year of fee payment: 3 |
    2020-06-26| PLFP| Fee payment|Year of fee payment: 5 |
    2021-06-30| PLFP| Fee payment|Year of fee payment: 6 |
    2022-01-07| TQ| Partial transmission of property|Owner name: UNIVERSITE GRENOBLE ALPES, FR Effective date: 20211130 Owner name: CENTRE HOSPITALIER UNIVERSITAIRE GRENOBLE, FR Effective date: 20211130 |
    优先权:
    申请号 | 申请日 | 专利标题
    FR1655187A|FR3052046B1|2016-06-07|2016-06-07|INTESTINAL SAMPLING DEVICE|FR1655187A| FR3052046B1|2016-06-07|2016-06-07|INTESTINAL SAMPLING DEVICE|
    CN201780048105.6A| CN109890298A|2016-06-07|2017-06-07|Enteron aisle sample collecting device|
    EP17727266.3A| EP3463100A1|2016-06-07|2017-06-07|Device for taking an intestinal sample|
    US16/307,885| US20190298318A1|2016-06-07|2017-06-07|Device for taking an intestinal sample|
    PCT/EP2017/063791| WO2017211872A1|2016-06-07|2017-06-07|Device for taking an intestinal sample|
    [返回顶部]